| Financial Year |
March 31 2023 |
| Monetary Funds |
2,970,137,526.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
49,546,057.84 |
| Accounts Receivable |
711,845,637.11 |
| Advances to Suppliers |
156,010,508.35 |
| Other Receivables |
100,403,962.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,708,713,871.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,329,571,350.26 |
| Total Current Assets |
13,138,118,202.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
246,651,437.29 |
| Investment Properties |
16,441,308.02 |
| Fixed Assetes |
262,230,473.29 |
| Under-construction Projects |
82,354,674.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
11,784,692.76 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
310,451,099.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
38,583,749.82 |
| Deferred Income Tax Assets |
177,761,183.01 |
| Other Non-Current Assets |
213,492,158.49 |
| Sub-Total of Non-Current Assets |
1,929,939,934.06 |
| Total Assets |
15,068,058,136.98 |
| Short-Term Loans |
904,025,781.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
113,739,031.45 |
| Accounts Payable |
303,477,543.86 |
| Accounts Received In Advance |
8,264,051.83 |
| Employee Compensation Payable |
134,333,420.03 |
| Taxes Payable |
212,174,743.80 |
| Interest Payable |
-- |
| Dividend Payable |
6,943,416.56 |
| Other payables |
333,619,913.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,545,925.52 |
| Other Current Liabilities |
7,572,105.92 |
| Sub-Total of Current Liabilities |
2,167,472,884.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
67,215,203.47 |
| Other Non-Current Liabilities |
46,891,831.43 |
| Sub-Total of Non-Current Liabilities |
269,070,110.93 |
| Total Liabilities |
2,436,542,995.02 |
| Paid-In Capital(Or Share Stock) |
603,317,210.00 |
| Capital Surplus |
1,093,716,530.99 |
| Surplus Reserve |
1,353,185,583.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,975,082,160.39 |
| Minority Stockholder's Interest |
519,443,611.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,112,071,530.28 |
| Owner's Equity（Stockholder's Equity） |
12,631,515,141.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,068,058,136.98 |
